跳至主要内容
临床试验/NCT07544576
NCT07544576Enrolling By Invitation4 期

Non-Inferiority Study Comparing Treatment of Primary Knee Osteoarthritis With Intra-Articular Triamcinolone Injections Using 40mg With Landmark Guidance and 20mg With Ultrasound Guidance: The PRECISION-Knee Trial (PRospective Evaluation of the Clinical Impact of Steroid Injection Options iN Knee Osteoarthritis)

Sosi Dzhugarian4 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年12月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
入组人数
140
试验地点
4
主要终点
Western Ontario and McMaster Universities Index

研究概览

简要总结

The purpose of this study is to determine whether a lower dose of corticosteroid injection with ultrasound-guidance for the treatment of knee osteoarthritis can be as effective as a higher dose that is landmark-guided. With landmark-guided dosing, it may be reasonable to use a higher amount of corticosteroid in order to ensure a sufficient amount of the medication is administered, however these injections carry the risk of side effects. Alternatively, with the use of ultrasound, it may be reasonable to use less corticosteroid, possibly decreasing the risk of side effects and increasing patient satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who have already been evaluated within at least one of the 4 study clinics with any of the 3 providers who will be administering the treatment
  • Males or females age 50 and older
  • Already had completion of imaging of the affected knee(s) via radiography and/or MRI
  • Imaging demonstrates osteoarthritis of any severity
  • Diagnosis of primary osteoarthritis of one or both knees
  • One or more symptoms associated with the osteoarthritis of at least one knee
  • Patients able to provide informed consent in English and/or Spanish

排除标准

  • Skin infection at or near area of injection site
  • Recent fracture of the same knee joint within past 6 months
  • Uncontrolled bleeding disorder
  • Intra-articular corticosteroid injection within past 3 months
  • Intra-articular HA injection within the past 3 months
  • Intra-articular PRP injection within the past 3 months
  • Presence of prosthetic knee joint in symptomatic knee
  • Inability to report symptoms due to cognitive impairment
  • Complete inability to ambulate, even with assistive device
  • Any person who is pregnant or less than 1 year post-menopause

研究组 & 干预措施

40mg landmark-guided triamcinolone knee joint injection

Active Comparator

干预措施: Triamcinolone knee injection without ultrasound guidance (Drug)

20mg ultrasound-guided triamcinolone knee injection

Experimental

干预措施: Triamcinolone knee injection with ultrasound guidance (Combination Product)

结局指标

主要结局

Western Ontario and McMaster Universities Index

时间窗: From enrollment to 3 months

Scores are on a scale of 0 through 96, with a higher score indicating a worse function level.

Pain Visual Analog Scale

时间窗: From enrollment to 3 months

scale of 0 through 10, with 10 being the highest pain level.

次要结局

  • Immediate change in pVAS (Pain Visual Analog Scale)(From enrollment to immediately after intervention)

研究者

发起方
Sosi Dzhugarian
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sosi Dzhugarian

Internal Medicine Physician

Community Memorial Health System

研究点 (4)

Loading locations...

相似试验